Abstract
Objective:
To evaluate the lipid-lowering effects, particularly changes in high-density lipoprotein (HDL) cholesterol, associated with atorvastatin use in a typical outpatient family medicine practice.
Design:
Retrospective case series.
Setting:
A community-based family medicine residency program.
Patients:
One hundred twenty-three patients with hyperlipidemia.
Interventions:
Treatment with atorvastatin to meet National Cholesterol Education Program (Adult Treatment Program) II goals.
Main Outcome Measures:
Fasting lipid profiles, including total cholesterol, low-density lipoprotein (LDL) cholesterol, HDL cholesterol, and triglycerides.
Results:
Atorvastatin lowered total cholesterol, LDL cholesterol, and triglycerides. HDL cholesterol was essentially unchanged from baseline to follow-up. In a subset of patients (∼50%), HDL cholesterol decreased by 13.1%. In the remainder of patients, HDL cholesterol increased by 10.7%. The decrease of HDL cholesterol was as much as 24 mg/dL.
Conclusions:
Atorvastatin is an effective agent for lowering total cholesterol, LDL cholesterol, and triglycerides. In a subset of patients, atorvastatin appeared to lower HDL cholesterol. Close monitoring of HDL cholesterol concentrations while patients are receiving atorvastatin is important.
Get full access to this article
View all access options for this article.